Last 12mo stats

mentions

voices

$PSTV

Plus Therapeutics

$PSTV

Plus Therapeutics

Past 12mo:16mentions1voices

All voices16 mentions since Jan 2026calls only

Loading price chart…

Frequently asked

Who mentions $PSTV most on Surfaced?

@acinvestorblog (Antonio Costa) mentions $PSTV most — 16 mentions in the past 12 months.

When was $PSTV first mentioned on Surfaced?

The earliest tracked mention of $PSTV in the Surfaced archive was on Jan 8, 2026.

How many voices track $PSTV?

1 FinTwit voice has mentioned $PSTV 16 times in the past 12 months.

What kind of voices mention $PSTV most?

$PSTV is mentioned most by Long Research voices on Surfaced.

Recent mentions

16 mentions

@acinvestorblogApr 10, 2026 · 3:12 PM

$PSTV – Last week I called for a possible bottom around $3 and got absolutely roasted by the shorts. Now the stock is trading above $5 … i do believe $LPCN is also forming a bottom pattern. Squeeze zone 2.25 (Mega gap there)

Open on X

@acinvestorblogApr 10, 2026 · 2:25 PM

$PSTV +20% bingo, what a great swing trade, keep sleeping on $LPCN insiders are buying like crazy for a reason.

Open on X

@acinvestorblogApr 10, 2026 · 1:56 PM

$PSTV sweet !!! Waiting for $LPCN 2.25 squeeze zone

Open on X

@acinvestorblogApr 9, 2026 · 4:41 PM

$PSTV breaks abv $4 😉

Open on X

@acinvestorblogApr 9, 2026 · 2:37 PM

$PSTV reversal trend taking place on decent volume. It has a gap over 4.35 https://t.co/kO5AAsCq5c

Open on X

@acinvestorblogApr 9, 2026 · 11:41 AM

$PSTV Another positive press release this morning. Eventually, the market will catch up and reflect the company's true value. https://t.co/9h3h31Ye9o

Open on X

@acinvestorblogApr 8, 2026 · 2:02 PM

$PSTV increased my position following the FDA news. I can wait now.

Open on X

@acinvestorblogApr 8, 2026 · 11:35 AM

$PSTV “Receiving orphan drug designation for REYOBIQ in pediatric malignant gliomas, including the broader scope for progressive pediatric ependymoma, is an important milestone and further validates our approach to delivering targeted radiotherapy directly to CNS tumors,” said Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics. “We believe REYOBIQ’s ability to deliver high-dose radiation precisely to tumor sites while minimizing exposure to healthy brain tissue has the potential to meaningfully improve outcomes in this underserved patient population. This orphan designation reinforces the potential applicability of REYOBIQ across a wider range of CNS tumor indications and our continued advancement of REYOBIQ across multiple CNS cancer indications.”

Open on X

@acinvestorblogApr 8, 2026 · 11:33 AM

$PSTV Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas https://t.co/cDKf8EmEnd

Open on X

@acinvestorblogApr 7, 2026 · 6:53 PM

$PSTV It appears someone may be selling shares they don’t actually own. Notice how the stock reacts every time the RSI hits extreme oversold levels around 18. Shares to borrow below 👇 https://t.co/MgreCWmuN2

Open on X

@acinvestorblogApr 7, 2026 · 4:32 PM

$PSTV There are clear signs of capitulation in the stock, which is now trading at extreme oversold readings. We could see a strong bounce at any moment. The company boasts a solid balance sheet with ample cash, a low float, and an impressive development pipeline. In a normal market, this news would almost certainly have pushed the stock significantly higher.

Open on X

@acinvestorblogApr 7, 2026 · 2:16 PM

$PSTV added more. Stock is now trading at cash levels. They have plenty of cash ($21.8M) and trading in extreme oversold levels. https://t.co/SPPQegZPdG

Open on X

@acinvestorblogApr 7, 2026 · 2:08 PM

Added $PLUG (pulled back to the pivot zone) $PSTV (great news today) for a swing trade. I buy the panic not the euphoria.

Open on X

@acinvestorblogApr 7, 2026 · 11:32 AM

$PSTV Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption https://t.co/7zEpRUeXqQ

Open on X

@acinvestorblogJan 8, 2026 · 1:11 PM

$PSTV D. Boral Capital analyst Jason Kolbert maintains Plus Therapeutics with a Buy and maintains $5 price target

Open on X

@acinvestorblogJan 8, 2026 · 12:36 PM

$PSTV Plus Therapeutics Completes Type B Meeting With FDA Over Next Steps On REYOBIQ Pivotal Study Strategy For Leptomeningeal Metastases

Open on X